Mercer Global Advisors
SANA icon

Mercer Global Advisors’s Sana Biotechnology SANA Stock Holding History

Mercer Global Advisors’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.2K Sell
12,379
-265
-2% -$854 ﹤0.01% 3531
2026
Q1 		$36.4K Buy
12,644
+2,422
+24% +$9.54K ﹤0.01% 3157
2025
Q4 		$41.6K Buy
10,222
+136
+1% +$609 ﹤0.01% 2805
2025
Q3 		$35.8K Buy
+10,086
New +$36.5K ﹤0.01% 2603

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Mercer Global Advisors's SANA Position: Q2 2026 in Review

Mercer Global Advisors reduced its Sana Biotechnology (SANA) stake by 2.1% in Q2 2026, selling an estimated $854 and leaving 12,379 shares worth $43.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3531.

Mercer Global Advisors first reported a position in SANA in Q3 2025 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Mercer Global Advisors held 12,379 shares of Sana Biotechnology worth $43.2K as of Q2 2026.
  • Mercer Global Advisors sold 265 Sana Biotechnology shares in Q2 2026, an estimated $854.
  • Sana Biotechnology made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3531 holding.
  • Mercer Global Advisors first reported a position in Sana Biotechnology in Q3 2025 and has held it in 4 quarters since.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.